Mar 2009 to 2000 Detective SergeantBergen County Police Academy
2009 to 2000 Criminal Investigation InstructorBoro of Lodi
Sep 2006 to 2000 School Resource OfficerState of The Art Security
Jan 2004 to 2000 Executive Protection DivisionLodi Police Department
Feb 2002 to Mar 2009 DetectiveLodi Police Department
Jan 1990 to Sep 2002 Police OfficerState of the Art Security
1991 to 1995 Self Defense Instructor - Division of Criminal JusticeBergen County Prosecutors Office Hackensack, NJ Oct 1988 to Dec 1990 Investigator
Education:
Bergen County Police Academy Mahwah, NJ 2007 to 2007 High Risk Survival CoarseBergen County Police Academy Mahwah, NJ 2004 to 2004 Methods of InstructionD.E.A Mahwah, NJ 2003 to 2003 Drug Enforcement Agency Narcotics CoarseState of the Art Security 2002 to 2002 CDT CertificationBergen County Police Academy 2002 to 2002 Fire and Arson DetectionBergen County Police Academy Mahwah, NJ 2001 to 2001 Field Training Officer CoarseBergen County Police Academy 2001 to 2001 Interview and Interrogation CoarseLodi High School Lodi, NJ 1993 High School DiplomaBergen County Police Academy Mahwah, NJ 1990New Jersey Criminal Justice Academy Trenton, NJ 1988 to 1988 P.T.C in InvestigationsSt. Thomas Aquinas College Sparkill, NY 1983 to 1987 Bachelor in Criminal Justice
Skills:
Surveillance, Interview & Interrogation, Investigations, Report Writing, Supervision, Public Speaking
Dr. Martin graduated from the University of Cincinnati College of Medicine in 1984. He works in Cincinnati, OH and specializes in Internal Medicine. Dr. Martin is affiliated with UC Medical Center.
Jay Keasling - Berkeley CA, US Vincent Martin - Kensington CA, US Douglas Pitera - Berkeley CA, US Seon-Won Kim - Jeongdong-myeon Sacheon, KR Yasuo Yoshikuni - Berkeley CA, US Jack Newman - San Francisco CA, US Artem Valentinovich Khlebnikov - Mountain View CA, US
Assignee:
The Regents of the University of California - Oakland CA
Methods for synthesizing isopentenyl pyrophosphate are provided. A first method comprises introducing into a host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate. A related method comprises introducing into a host microorganism an intermediate in the mevalonate pathway and at least one heterologous nucleic acid sequence, each sequence coding for an enzyme in the mevalonate pathway necessary for converting the intermediate into isopentenyl pyrophosphate. The invention also provides nucleic acid sequences, enzymes, expression vectors, and transformed host cells for carrying out the methods.
Methods for synthesizing amorpha-4,11-diene synthase from isopentenyl pyrophosphate are provided. A first method comprises introducing into a host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate. Amorpha-4,11-diene synthase is then produced using an optimized amorpha-4,11-diene synthase gene. The invention also provides nucleic acid sequences, enzymes, expression vectors, and transformed host cells for carrying out the methods.
Method For Identifying A Biosynthetic Pathway Gene Product
Jay Keasling - Berkely CA, US Jack Newman - Berkeley CA, US Douglas Pitera - Oakland CA, US Sydnor Withers - Richmond CA, US Keith Reiling - San Francisco CA, US Vincent Martin - Kensington CA, US
International Classification:
C12Q 1/68 C12N 15/74
US Classification:
435006000, 435455000, 435471000
Abstract:
The present invention provides isolated, genetically modified host cells, where a host cell is genetically modified with a nucleic acid that includes a nucleotide sequence encoding a biosynthetic pathway enzyme. Synthesis of the enzyme in the host cell results in conversion of a substrate for the enzyme into a biosynthetic pathway intermediate, which intermediate is produced in an amount effective to inhibit growth of the genetically modified host cell. The present invention further provides compositions and kits comprising a subject genetically modified host cell. Subject host cells are useful for identifying a gene product having activity in a biosynthetic pathway. The present invention further provides methods of identifying a gene product having activity in a biosynthetic pathway.
JAY KEASLING - Berkeley CA, US VINCENT MARTIN - Kensington CA, US DOUGLAS PITERA - Oakland CA, US SEON-WON KIM - Jeongdong-Myeon, Sacheon City, KR SYDNOR WITHERS - Richmond CA, US YASUO YOSHIKUNI - Berkeley CA, US JACK NEWMAN - Berkeley CA, US ARTEM KHLEBNIKOV - Mountain View CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - San Francisco CA
Methods for synthesizing isopentenyl pyrophosphate are provided. A first method comprises introducing into a host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate. A related method comprises introducing into a host microorganism an intermediate in the mevalonate pathway and at least one heterologous nucleic acid sequence, each sequence coding for an enzyme in the mevalonate pathway necessary for converting the intermediate into isopentenyl pyrophosphate. The invention also provides nucleic acid sequences, enzymes, expression vectors, and transformed host cells for carrying out the methods.
Jack Newman - Berkeley CA, US Neil Renninger - Albany CA, US Vincent Martin - Kensington CA, US Jay Keasling - Berkeley CA, US Keith Reiling - Oakland CA, US
International Classification:
G01N 33/573 C12Q 1/68
US Classification:
435006000, 435007400
Abstract:
The present invention provides a method of identifying an enzyme, the method generally involving contacting a sample containing an enzyme with a selected enzyme substrate, where the contacting provides for covalent binding of the substrate to an amino acid of the enzyme to form a covalently modified enzyme; and determining the amino acid sequence of at least a portion of the covalently modified enzyme, using any available peptide sequencing technology, such as tandem mass spectrometry. The present invention further provides methods of identifying a nucleic acid encoding an enzyme, the methods generally involving identifying an enzyme; and, based on the amino acid sequence of at least a portion of the enzyme, designing nucleic acid probes or primers that hybridize to the nucleic acid encoding the enzyme.
Isbn (Books And Publications)
A House Divided: The Parting of the Ways Between Synagogue and Church
r migraine. Dr. Vincent Martin, the director of the Headache and Facial Pain Program at the University of Cincinnati College of Medicine, sighed when I asked why there arent more studies like this. Theyre expensive to do, he said, and the state of migraine funding is abysmal. Migraine is not prio
Date: May 01, 2024
Category: Health
Source: Google
Avian influenza update: China, Alabama and Tennessee
To protect human health and peoples livelihoods, it is essential to tackle the disease at its source in poultry: efforts need to target eliminating H7N9 from affected farms and markets, said Vincent Martin, FAOs Representative in China.
"Women have been telling doctors that their migraine headaches worsen around menopause, and now we have proof they were right," study author Dr. Vincent Martin, co-director of the Headache and Facial Pain Program at the University of Cincinnati Neuroscience Institute, said in a news release.
Date: Jan 22, 2016
Category: Health
Source: Google
New Study Investigates Link Between Asthma and Migraine
Lead study author Dr. Vincent Martin explains, If you have asthma along with episodic or occasional migraine, then your headaches are more likely to evolve into a more disabling form known as chronic migraine. The co-director for the Headache and Facial Pain Program at the University of Cincinnati
Date: Dec 01, 2015
Category: Health
Source: Google
If You Have Asthma, You're Likelier To Have Migraines
On the other hand, around 7% of adults have asthma. Those who suffer from the latter were found to be more likely to experience chronic migraines than those who did not have the condition. Lead author of the study, Dr. Vincent Martin, stated that they were, in fact, twice as likely.
Date: Dec 01, 2015
Category: Health
Source: Google
Asthma increases risk of future chronic migraines, study reveals
with episodic migraine and asthma at baseline were more than twice as likely to develop chronic migraine after one year of follow-up as compared to those with episodic migraine but not asthma," said Dr. Vincent Martin, lead author and professor of medicine in UC's Division of General Internal Medicine.
"If you have asthma along with episodic or occasional migraine, then your headaches are more likely to evolve into a more disabling form known as chronic migraine," explains Vincent Martin, MD, professor of medicine in UC's Division of General Internal Medicine, co-director of the Headache and Facia
Date: Nov 30, 2015
Category: Health
Source: Google
Scientists finish recipe for homebrewed heroin, using genetically modified yeast
"We're certainly not aiming for the illicit drugs market, that's for sure," said Vincent Martin, a microbiologist at Concordia University in Quebec and co-author of the study. "We realised that we're entering into a brave new territory here. Me and my collaborators felt various regulatory bodies sho